Standout Papers

Efficacy and Safety of Tr... 2015 2026 2018 2022 2015 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
    2015 575 citations George D. Demetri, Margaret von Mehren et al. Journal of Clinical Oncology profile →

Immediate Impact

51 hit
Sub-graph 1 of 24

Citing Papers

Multimodal smart systems reprogramme macrophages and remove urate to treat gouty arthritis
2024 Hit
Public Health Challenges and Responses to the Growing Ageing Populations
2024 Hit
2 intermediate papers

Works of A. Elias being referenced

Contribution of uric acid to cancer risk, recurrence, and mortality
2012

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
A. Elias 512 397 187 155 153 7 784
Kelly Scheu 357 0.7× 386 1.0× 80 0.4× 91 0.6× 153 1.0× 10 719
Juan C. Gonzalez-Vitale 440 0.9× 192 0.5× 70 0.4× 210 1.4× 101 0.7× 9 903
Jean Philippe Spano 362 0.7× 418 1.1× 44 0.2× 114 0.7× 154 1.0× 16 810
Farid Fata 392 0.8× 584 1.5× 238 1.3× 62 0.4× 28 0.2× 15 779
Ketki Tendulkar 265 0.5× 345 0.9× 45 0.2× 62 0.4× 167 1.1× 22 643
Samantha Bonazzola 187 0.4× 73 0.2× 85 0.5× 64 0.4× 169 1.1× 7 844
Ursula Vogl 416 0.8× 397 1.0× 297 1.6× 70 0.5× 339 2.2× 20 876
Hernan G. Vasquez 189 0.4× 214 0.5× 91 0.5× 35 0.2× 319 2.1× 15 808
Sunfa Cheng 113 0.2× 136 0.3× 118 0.6× 57 0.4× 409 2.7× 7 871
Naadiya Carrim 109 0.2× 119 0.3× 132 0.7× 72 0.5× 169 1.1× 9 891

All Works

Loading papers...

Rankless by CCL
2026